Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Department of Anesthesiology, Columbia University Irving Medical Center, New York, New York, United States of America.
PLoS One. 2021 Jul 9;16(7):e0253990. doi: 10.1371/journal.pone.0253990. eCollection 2021.
BACKGROUND: Severe acute post-cesarean delivery (CD) pain has been associated with an increased risk for persistent pain and postpartum depression. Identification of women at increased risk for pain can be used to optimize post-cesarean analgesia. The impact of labor prior to CD (intrapartum CD) on acute post-operative pain and opioid use is unclear. We hypothesized that intrapartum CD, which has been associated with both increased inflammation and affective distress related to an unexpected surgical procedure, would result in higher postoperative pain scores and increased opioid intake. METHODS: This is a secondary analysis of a prospective cohort study examining opioid use up to 2 weeks following CD. Women undergoing CD at six academic medical centers in the United States 9/2014-3/2016 were contacted by phone two weeks following discharge. Participants completed a structured interview that included questions about postoperative pain scores and opioid utilization. They were asked to retrospectively estimate their maximal pain score on an 11-point numeric rating scale at multiple time points, including day of surgery, during hospitalization, immediately after discharge, 1st week, and 2nd week following discharge. Pain scores over time were assessed utilizing a generalized linear mixed-effects model with the patient identifier being a random effect, adjusting for an a priori defined set of confounders. A multivariate negative binomial model was utilized to assess the association between intrapartum CD and opioid utilization after discharge, also adjusting for the same confounders. In the context of non-random prescription distribution, this model was constructed with an offset for the number of tablets dispensed. RESULTS: A total of 720 women were enrolled, 392 with and 328 without labor prior to CD. Patients with intrapartum CD were younger, less likely to undergo repeat CD or additional surgical procedures, and more likely to experience a complication of CD. Women with intrapartum CD consumed more opioid tablets following discharge than women without labor (median 20, IQR 10-30 versus 17, IQR 6-30; p = 0.005). This association persisted after adjustment for confounders (incidence rate ratio 1.16, 95% CI 1.05-1.29; p = 0.004). Pain scores on the day of surgery were higher in women with intrapartum CD (difference 0.91, 95% CI 0.52-1.30; adj. p = <0.001) even after adjustment for confounders. Pain scores at other time points were not meaningfully different between the two groups. CONCLUSION: Intrapartum CD is associated with worse pain on the day of surgery but not other time points. Opioid requirements following discharge were modestly increased following intrapartum CD.
背景:严重的急性剖宫产术后(CD)疼痛与持续性疼痛和产后抑郁的风险增加有关。识别疼痛风险较高的女性可以优化剖宫产术后的镇痛效果。在 CD 之前进行分娩(产时 CD)对急性术后疼痛和阿片类药物使用的影响尚不清楚。我们假设,产时 CD 与炎症增加以及与意外手术相关的情感困扰有关,这将导致更高的术后疼痛评分和阿片类药物摄入增加。
方法:这是一项前瞻性队列研究的二次分析,该研究检查了 CD 后 2 周内阿片类药物的使用情况。2014 年 9 月至 2016 年 3 月期间,美国六家学术医疗中心的 CD 产妇在出院后两周内通过电话联系。参与者完成了一项结构访谈,其中包括术后疼痛评分和阿片类药物使用情况的问题。他们被要求回顾性估计他们在多个时间点的最大疼痛评分,包括手术当天、住院期间、出院后立即、第 1 周和出院后第 2 周,使用数字评分量表进行评估。利用广义线性混合效应模型评估随时间变化的疼痛评分,患者标识符为随机效应,调整了预先定义的一组混杂因素。利用多变量负二项式模型评估产时 CD 与出院后阿片类药物使用之间的关联,也调整了相同的混杂因素。在非随机处方分布的情况下,该模型的构建带有分配的片剂数量偏移。
结果:共纳入 720 名女性,其中 392 名有产时 CD,328 名没有。产时 CD 的患者年龄较小,再次进行 CD 或其他手术的可能性较小,并且更有可能出现 CD 并发症。产时 CD 的女性出院后消耗的阿片类药物片剂比没有产时 CD 的女性多(中位数 20,IQR 10-30 与 17,IQR 6-30;p=0.005)。在调整混杂因素后,这种关联仍然存在(发病率比 1.16,95%CI 1.05-1.29;p=0.004)。产时 CD 的女性手术当天的疼痛评分更高(差值 0.91,95%CI 0.52-1.30;调整后 p<0.001),即使在调整了混杂因素后也是如此。两组在其他时间点的疼痛评分没有明显差异。
结论:产时 CD 与手术当天的疼痛加剧有关,但与其他时间点无关。产时 CD 后出院后的阿片类药物需求略有增加。
Am J Obstet Gynecol. 2018-4-7
JAMA Netw Open. 2023-10-2
JAMA Netw Open. 2019-7-3
Obstet Gynecol. 2017-7
J Pain Res. 2024-1-4
Clin Obstet Gynecol. 2017-12
Obstet Gynecol. 2017-7